BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16317100)

  • 1. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
    Corazza F; Hermans C; D'Hondt S; Ferster A; Kentos A; Benoît Y; Sariban E
    Blood; 2006 Mar; 107(6):2525-30. PubMed ID: 16317100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
    Matsumura I; Ikeda H; Kanakura Y
    Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
    Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
    Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thrombopoietin on acute myelogenous leukemia blasts.
    Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Ishikawa J; Horikawa Y; Hashimoto K; Moriyama Y; Tsujimura T; Nishiura T
    Blood; 1995 Jul; 86(2):703-9. PubMed ID: 7541672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
    Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the MPL receptor in myeloproliferative disorders.
    Kaushansky K
    Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
    Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
    Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
    Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research Status of TPO/c-MPL Signaling Pathway in Acute Myeloid Leukemia--Review].
    Wang N; Zhu HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1351-1354. PubMed ID: 34362529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thrombopoietin receptor and its functional role in human B-precursor leukemia cells with 11q23 translocation or Philadelphia chromosome.
    Iijima K; Sugita K; Inukai T; Goi K; Tezuka T; Uno K; Sato H; Kagami K; Nakazawa S
    Leukemia; 2000 Sep; 14(9):1598-605. PubMed ID: 10995006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
    Souyri M
    Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
    Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
    Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia.
    Rauch PJ; Ellegast JM; Widmer CC; Fritsch K; Goede JS; Valk PJ; Löwenberg B; Takizawa H; Manz MG
    Blood; 2016 Nov; 128(18):2253-2257. PubMed ID: 27574191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy.
    Kaban K; Kantarjian H; Talpaz M; O'Brien S; Cortes J; Giles FJ; Pierce S; Albitar M
    Cancer; 2000 Feb; 88(3):570-6. PubMed ID: 10649249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.